Carbidopa And Levodopa Tablet, Extended Release
Product Images NDC 72162-2194

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 72162-2194). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbidopa Chemical Structure (Cls Tabs Carbi Str)

Chemical structure of Carbidopa, showing its molecular formula with hydroxyl groups, a benzene ring, and hydrazine side chain along with a water molecule (hydrate).*

FDA Label Image

Levodopa Chemical Structure (Cls Tabs Levo Str)

Chemical structure of the active ingredient carbidopa, depicting its molecular arrangement with hydroxyl groups and an amino acid side chain.*

FDA Label Image

Label (Lbl721622194)

Label for Carbidopa and Levodopa Extended-Release Tablets, USP 25 mg/100 mg. The label includes the NDC 72162-2194-1, a barcode, and storage instructions. It states the product contains 25 mg Carbidopa and 100 mg Levodopa per tablet, with 100 tablets per container. The product is relabeled by Bryant Ranch Prepack and manufactured by ScieGen Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.